Viewing Study NCT06059495


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-01-03 @ 6:09 AM
Study NCT ID: NCT06059495
Status: RECRUITING
Last Update Posted: 2024-02-05
First Post: 2023-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module